ILMN

#521
Illumina, Inc. - Common Stock
159.5 7 USD
+0.55%
부문: 헬스케어
베이스: USD
수익 통화: USD
일일 변동 비율
158.10
160.91
년간 변동
78.80
160.91
일일 변동
+0.55%
월간 변동
+30.55%
6달 변화
+22.86%
년간 변동율
+91.19%
이전 종가
158.7 0
Open
159.9 6
저가
158.1 0
High
160.9 1
양
482
전체 차트 열기 Full chart

Financials

개요 성명 통계
4분기 연간
  • Market Capitalization 24.14 B
  • Employee 8 650
  • Founded 1998
  • CEO Jacob Thaysen
  • Website www.illumina.com
  • Headquarter Delaware, United States
  • FIGI BBG000DSMS70
  • Industry 분석 & 리서치
총매출
순이익
주당 순이익(기본 EPS)
총부채
잉여 현금 흐름
현금 및 현금성 자산
주가수익비율
24.68
주가매출액비율
4.83

Illumina, Inc. - Common Stock

Illumina, Inc. is an American biotechnology company, headquartered in San Diego, California. Incorporated on April 1, 1998, Illumina develops, manufactures, and markets integrated systems for the analysis of genetic variation and biological function. The company provides a line of products and services that serves the sequencing, genotyping and gene expression, and proteomics markets, and serves more than 155 countries. Illumina's customers include genomic research centers, pharmaceutical companies, academic institutions, clinical research organizations, and biotechnology companies.

뉴스